|

D3L-001 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • D3 Bio (Wuxi) Co., Ltd1

Indications

  • HER-2 Positive Advanced Solid Tumors1
  • Cancer1

Stanford, California1 trial

A Study of D3L-001 as Monotherapy in Subjects With HER2-Positive Advanced Solid Tumors

D3 Bio Investigative Site

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.